Two-Year Outcomes of Less Invasive Surfactant Administration Among Preterm Neonates
JAMA Network Open 10.1001/jamanetworkopen.2026.3852March 31, 2026 at 11:00 AM EDT
In preterm neonates supported with continuous positive airway pressure (CPAP), is early caffeine administration and less invasive surfactant administration (LISA) associated with a lower frequency of death or moderate to severe neurodevelopmental impairment (NDI) at 2 years compared with CPAP support alone?In this secondary analysis of a randomized clinical trial of 180 infants born at a gestational age of 24 to 29 weeks 6 days, 82% had follow-up data, and death or NDI occurred in 23% receiving LISA compared with 33% receiving CPAP alone. This difference was not statistically significant.These findings suggest that among preterm infants supported with CPAP, LISA was not associated with a reduction in death or NDI at 2 years.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.